The Medscape Global team is bringing their leading cardiology education and proven impact to the European Society of ...

Novo Nordisk has announced the appointment of Maziar Mike Doustdar as its new president and chief executive officer (CEO).

This Phase III global clinical trial for patients with either stage IIIB or IV unresectable melanoma involved 118 research ...

In response, medical communications planning has become increasingly integrated, allowing customised user experiences across ...

Patient engagement is one of the most reliable ways to drive long-term health outcomes and a critical benchmark for ...

MSD – known as Merck & Co in the US and Canada – has announced that its anti-PD-1 therapy Keytruda (pembrolizumab) has been ...

It is hoped the new formulation will offer patients greater freedom and flexibility compared to the liquid version ...

Medical and scientific innovation are in a fast lane closely pursued by digital advances but their dynamism can mute a vital ...

Apogee Therapeutics has shared positive 16-week results from a mid-stage study of its investigational anti-IL-13 antibody in ...

Rezpegaldesleukin, which has already been granted FDA fast track designation for moderate-to-severe atopic dermatitis, is ...

Eli Lilly has shared positive top-line results from a head-to-head study of its non-covalent Bruton’s tyrosine kinase (BTK) ...

AstraZeneca (AZ) has announced that Imfinzi (durvalumab) in combination with Imjudo (tremelimumab) has been recommended by ...